by Heidi Riley
Somru BioScience Inc. develops breakthrough antibody technology for research, diagnostic and therapeutic applications. The company uses antibodies to generate reagents that accelerate biosimilar research and development.
The company has stepped up during the COVID-19 pandemic to be part of the solution.
They are working on multiple projects to develop research solutions to combat the outbreak.
“We are honoured to be a part of Premier King’s Council on Recovery and Growth,” says Mohammed Moin, CEO of Somru BioScience Inc. in Charlottetown.
“The work of this group will be critical in establishing a plan for recovery and growth potential for our province over the next one, two, five and 10 years. Somru will play a vital role to accelerate the economic growth in post-corona world.
“We export to 27 countries now, and are looking to double our workforce in 2022,” Moin says.
“We are looking to grow further in Europe and Asia with a strong focus on improvements to our systems and processes such as automated kit assembly, electronic assay worksheets, and data analysis tools.”
For more information, visit www.somrubioscience.com.